PPARA and cyclic hematopoiesis: In conclusion, our data highlight that PPAR silencing triggers morphological and molecular changes that prompt hypertrophy in rat cardiomyoblasts, and that antioxidant and anti-ferroptosis Ebs treatment can revert these modifications, thus opening a new scenario for deep pre-clinical studies on the therapeutic value of this small molecule in human CH.